A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2001
10/25/2001	WO2001021605A3 Method for extracting compounds of furan lipids and polyhydroxylated fatty alcohols of avocado, composition based on said compounds and use of said compounds in therapy, cosmetics and food
10/25/2001	WO2001012790A3 Isomerase proteins
10/25/2001	WO2000061541A8 Pharmaceutical compounds
10/25/2001	WO2000056737A9 Calanolides for inhibiting btk
10/25/2001	US20010034436 Polynucleotide and polypeptides, screening for antibiotic activity, Staphylococcus
10/25/2001	US20010034364 Isoprenoid pathway inhibitors for stimulating bone growth
10/25/2001	US20010034354 Antiulcer agents
10/25/2001	US20010034348 Nitric oxide synthase inhibitor; nervous system disorders
10/25/2001	US20010034340 Hormone replacement therapy
10/25/2001	US20010034337 Antiproliferative agents
10/25/2001	US20010034331 Isolated polypeptide
10/25/2001	US20010033864 Low dose entecavir formulation and use
10/25/2001	US20010033834 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
10/25/2001	DE10019195A1 Gene complex for reversible cell immortalization, useful for expanding cells for cell replacement therapy of e.g. neurodegenerative disease, contains removable immortalizing gene
10/25/2001	CA2747325A1 Albumin fusion proteins
10/25/2001	CA2407531A1 Imidazopyrimidine derivatives and triazolopyrimidine derivatives
10/25/2001	CA2406947A1 Methods for prevention and treatment of gastrointestinal disorders
10/25/2001	CA2406403A1 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof
10/25/2001	CA2406378A1 Targeted vaccine delivery systems
10/25/2001	CA2406245A1 Il-174 uses, compositions and methods
10/25/2001	CA2406220A1 Antibody alpha4beta7 integrin and its use to treat inflammatory bowel disease
10/25/2001	CA2406171A1 Reversible immortalization of cells
10/25/2001	CA2406023A1 Decreasing the intracellular level of beta-catenin by administering hydroxymatairesinol
10/25/2001	CA2405709A1 Albumin fusion proteins
10/25/2001	CA2405701A1 Albumin fusion proteins
10/25/2001	CA2405597A1 Halogentated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors
10/25/2001	CA2405563A1 Albumin fusion proteins
10/25/2001	CA2405557A1 Albumin fusion proteins
10/25/2001	CA2405550A1 Albumin fusion proteins
10/25/2001	CA2405525A1 Albumin fusion proteins
10/25/2001	CA2405451A1 Molecules associated with human reproduction
10/25/2001	CA2405377A1 Nutritional modules
10/25/2001	CA2404639A1 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
10/25/2001	CA2404117A1 Use of ngf-antagonists for the prevention or treatment of chronic visceral pain
10/25/2001	CA2403644A1 Drug metabolizing enzymes
10/24/2001	EP1148064A1 Lactobacillus johnsonii bacteriocin, active against Helicobacter pylori
10/24/2001	EP1147776A2 Use of botulinum toxin type B for the manufacture of a medicament for the treatment of muscle spasms
10/24/2001	EP1147775A2 Use of botulinum toxin type B for the manufacture of a medicament for reducing pain associated with a muscle disorder
10/24/2001	EP1147179A2 Human liver progenitors
10/24/2001	EP1147138A1 Hydrophilic ampholytic polymer
10/24/2001	EP1147136A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
10/24/2001	EP1147121A2 Ketolide antibiotics
10/24/2001	EP1147114A1 Novel aralkyl amines of spirofuropyridines useful in therapy
10/24/2001	EP1147110A1 Pyrazino(aza)indole derivatives
10/24/2001	EP1147104A1 Aromatic heterocyclic compounds as antiinflammatory agents
10/24/2001	EP1147102A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
10/24/2001	EP1147101A1 Reverse hydroxamate inhibitors of matrix metalloproteinases
10/24/2001	EP1147097A1 Peptidyl heterocyclic ketones useful as tryptase inhibitors
10/24/2001	EP1147095A1 2, 3, 4, 5-tetrahydro-1h-[1, 4] benzodiazepine-3-hydroxamic acids as matrix metalloproteinase inhibitors
10/24/2001	EP1147092A1 Substituted imidazoles, their preparation and use
10/24/2001	EP1147091A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/24/2001	EP1147089A1 Phenylphenanthridines with pde-iv inhibiting activity
10/24/2001	EP1147084A1 Phenylsulphonyl derivatives as 5-ht receptor ligands
10/24/2001	EP1147080A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
10/24/2001	EP1147078A1 Acetylenic (beta)-sulfonamido and phosphinic acid amide hydroxamic acid tace inhibitors
10/24/2001	EP1146899A1 Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
10/24/2001	EP1146888A2 Specific therapeutic interventions obtained by interference with redistribution and/or targetting
10/24/2001	EP1146885A1 Pre-conditioning against cell death
10/24/2001	EP1146883A1 Modulation of immune response by ribavirin
10/24/2001	EP1146874A1 Vitronectin receptor antagonist
10/24/2001	EP1146870A1 Antioxidant compositions and methods for companion animals
10/24/2001	EP1146868A1 Anti-inflammatory agents
10/24/2001	EP1146857A2 Materials and methods for making improved micelle compositions
10/24/2001	EP1146790A1 Compounds and methods
10/24/2001	EP1035824A4 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
10/24/2001	EP0869955B1 N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists
10/24/2001	CN1319139A Polynucleotide constructs and uses thereof
10/24/2001	CN1319133A Short peptides which selectively modulate activity of protein kinases
10/24/2001	CN1319101A Tetrahydropyridoethers
10/24/2001	CN1319097A Benzoxazine and benzothiazine derivatives and their use in medicines
10/24/2001	CN1319094A Imidazolyl derivatives
10/24/2001	CN1319093A Aminoalkyl-3,4-dihydroquindine derivates as No-synthase inhibitors
10/24/2001	CN1319009A Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
10/24/2001	CN1318565A Humanized hapotitis A virus neutralizing genetically engineered total antibody
10/24/2001	CN1318415A Buccal tablet of epidermal growth factor
10/24/2001	CN1318401A Medicine for strengthening physique and resisting senility
10/24/2001	CN1318394A 延年益寿保健药品 Longevity health drugs
10/24/2001	CN1318393A Allicin health care liquid
10/24/2001	CN1318386A Toothache treating medicine of capillary artemisia
10/24/2001	CN1318377A Hepatosis treating Chinese medicine
10/24/2001	CN1318363A Health care gargle and its preparation
10/24/2001	CN1318362A Caries preventing Magnolia Officinalis toothpaste
10/24/2001	CN1073445C Medicinal mixture for treating infantile diarrhea and its preparing process
10/24/2001	CN1073440C Tea with functions of dispelling effect of alcohol, nourishing stomach and protecting liver
10/24/2001	CN1073437C Chinese medicine for treating digestive tract inflammation and ulcer and its prep.
10/24/2001	CN1073431C Medicine for conditioning intestine and treating diarrhea
10/24/2001	CN1073427C Gastritis pills
10/24/2001	CN1073426C Medicine for lithiasis
10/24/2001	CN1073425C Clystering liquid for curing lupus colonitis
10/24/2001	CN1073424C Preparation of tablet for preventing and curing dental diseases
10/23/2001	US6307092 Potent ocular hypotensives and are particularly suited for the management of glaucoma.
10/23/2001	US6307089 Biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases
10/23/2001	US6307061 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
10/23/2001	US6307060 Antispasmodic agents
10/23/2001	US6307049 Useful for treating hair loss in mammals, including arresting and/or reversing hair loss and promoting hair growth.
10/23/2001	US6307022 Def
10/23/2001	US6306908 Proteins, carbohydrates and lipids
10/23/2001	US6306897 Calanolides for inhibiting BTK
10/23/2001	US6306887 Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
10/23/2001	US6306886 Solid polymorph anticoagulants

1 ... 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 ... 1258